Minnow Street Minnow Street
Buy Day today: Neutral (53) Mixed market breadth · no major macro event

Johnson & Johnson (JNJ)

Healthcare Drug Manufacturers - General
256.40 $
+0.2% vs. previous close
Closing price · As of: 31. Jul 2026

Johnson & Johnson (JNJ) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 199,210 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Balance Sheet JNJ
Tick rows to compare them in a chart (up to 4) 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
130,358 133,411 141,208 157,303 152,954 157,728 174,894 182,018 187,378 167,558 180,104 199,210
59,311 60,210 65,032 43,088 46,033 45,274 51,237 60,979 55,294 53,495 55,893 55,624
14,523 13,732 18,972 17,824 18,107 17,305 13,985 14,487 12,889 21,859 24,105 19,709
33,089 38,376 41,907 18,296 19,687 19,287 25,185 31,608 22,281 22,927 24,522 20,102
10,985 10,734 11,699 13,490 14,098 14,481 13,576 18,984 16,915 14,873 18,927 17,178
8,184 8,053 8,144 8,765 8,599 9,020 9,344 10,387 10,268 11,181 12,444 14,191
16,126 15,905 15,912 17,005 17,035 17,658 18,766 18,962 19,803 20,898 21,618 24,469
21,832 21,629 22,805 31,906 30,453 33,639 36,393 35,246 36,047 36,558 44,200 48,772
27,222 25,764 26,876 53,228 47,611 47,643 53,402 46,392 38,489 34,175 37,618 50,403
61,367 62,261 70,790 97,143 93,202 98,257 111,616 107,995 110,574 98,784 108,614 117,666
25,085 27,747 26,287 30,537 31,230 35,964 42,493 45,226 55,802 46,282 50,321 54,126
3,638 7,004 4,684 3,906 2,796 1,202 2,631 3,766 12,756 3,451 5,983 8,495
7,633 6,668 6,918 7,310 7,537 8,544 9,505 11,055 9,889 9,632 10,311 11,991
15,122 12,857 22,442 30,675 27,684 26,494 32,635 29,985 26,888 25,881 30,651 39,438
69,752 71,150 70,418 60,160 59,752 59,471 63,278 74,023 76,804 68,774 71,490 81,544
97,245 103,879 110,551 101,793 106,216 110,659 113,890 123,060 128,345 153,843 155,791 168,978
2,864 2,813 2,789 2,745 2,729 2,684 2,671 2,674 2,664 2,560 2,429 2,429

Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?